Gastroenterology and Hepatology from Bed to Bench

. Jemal, A., R. Siegel, J. Xu, and E. Ward. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.

Jemal, A., R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.

Iodice, S., S. Gandini, P. Maisonneuve, and A.B. Lowenfels. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008; 393: 535-45.

McWilliams, R.R., W.R. Bamlet, J.M. Cunningham, E.L. Goode, M. de Andrade, L.A. Boardman, et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008; 68: 4928-35.

Neoptolemos, J.P., D.D. Stocken, H. Friess, C. Bassi, J.A. Dunn, H. Hickey, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350: 1200-10.

Oettle, H., S. Post, P. Neuhaus, K. Gellert, J. Langrehr, K. Ridwelski, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. Jama 2007; 297: 267-77.

Yoo, Y.A., Y.H. Kim, J.S. Kim, and J.H. Seo. The functional implications of Akt activity and TGF-beta signaling in tamoxifen-resistant breast cancer. Biochim Biophys Acta 2008; 1783: 438-47.

Arteaga, C.L. Inhibition of TGFbeta signaling in cancer therapy. Curr Opin Genet Dev 2006; 16: 30-7.

Lawrence, D.A. Transforming growth factor-beta: an overview. Kidney Int Suppl 1995; 49: S19-23.

Lawrence, D.A. Transforming growth factor-beta: a general review. Eur Cytokine Netw 1996; 7: 363-74.

Roberts, A.B., M.B. Sporn, R.K. Assoian, J.M. Smith, N.S. Roche, L.M. Wakefield, et al. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986; 83: 4167-71.

Yang, E.Y. and H.L. Moses. Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990; 111: 731-41.

Wu, G.Y., T. Hasenberg, R. Magdeburg, R. Bonninghoff, J.W. Sturm, and M. Keese. Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer. World J Surg 2009; 33: 124-9.

Grainger, D.J., P.R. Kemp, J.C. Metcalfe, A.C. Liu, R.M. Lawn, N.R. Williams, et al. The serum concentration of active transforming growth factor-beta is severely depressed in advanced atherosclerosis. Nat Med 1995; 1: 74-9.

Romani, S., P. Azimzadeh, S.R. Mohebbi, S. Kazemian, S. Almasi, H. Naghoosi, et al. Investigation of Transforming Growth Factor-beta1 Gene Polymorphisms Among Iranian Patients With Chronic Hepatitis C. Hepat Mon 2011; 11: 901-6.

Liu, Y., W. Zhou, and D.W. Zhong. Meta-analyses of the associations between four common TGF-beta1 genetic polymorphisms and risk of colorectal tumor. Tumour Biol 2012; 33: 1191-9.

Liberek, A., J. Jakobkiewicz-Banecka, A. Kloska, J. Swiderska, Z. Kmiec, G. Luczak, et al. Clinical parameters of inflammatory bowel disease in children do not correlate with four common polymorphisms of the transforming growth factor beta1 gene. Acta Biochim Pol 2011; 58: 641-4.

Fukai, Y., M. Fukuchi, N. Masuda, H. Osawa, H. Kato, T. Nakajima, et al. Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int J Cancer 2003; 104: 161-6.

Yang, W.F., J.M. Yu, W.S. Zuo, and S.Z. Wang. [Expression of CD80, CD86, TGF-beta1 and IL-10 mRNA in the esophageal carcinoma]. Zhonghua Zhong Liu Za Zhi 2006; 28: 762-5.

Grainger, D.J., K. Heathcote, M. Chiano, H. Snieder, P.R. Kemp, J.C. Metcalfe, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8: 93-7.

Miller, S.A., D.D. Dykes, and H.F. Polesky. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.

Genkinger, J.M., D. Spiegelman, K.E. Anderson, L. Bergkvist, L. Bernstein, P.A. van den Brandt, et al. Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev 2009; 18: 765-76.

Massague, J., S.W. Blain, and R.S. Lo. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295-309.

Wu, G.Y., Q. Lu, T. Hasenberg, M. Niedergethmann, S. Post, J.W. Sturm, et al. Association between EGF, TGF-{beta}1, TNF-{alpha} gene polymorphisms and cancer of the pancreatic head. Anticancer Res 2010; 30: 5257-61.

Nikolova, P.N., G.P. Pawelec, S.M. Mihailova, M.I. Ivanova, A.P. Myhailova, D.N. Baltadjieva, et al. Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population. Cancer Immunol Immunother 2007; 56: 371-9.

Hu, G.R., B.X. Zheng, and Z.F. Liu. Association between TGFB1 915G/C polymorphism and susceptibility to chronic hepatitis C virus infection: A meta-analysis. Biomed Rep 2014; 2: 239-44.

Hosseini Razavi, A., P. Azimzadeh, S.R. Mohebbi, S.M. Hosseini, S. Romani, M. Khanyaghma, et al. Lack of Association Between Transforming Growth Factor Beta 1 -509C/T and +915G/C Polymorphisms and Chronic Hepatitis B in Iranian Patients. Hepat Mon 2014; 14: e13100.

Kang, D., K.M. Lee, S.K. Park, S.I. Berndt, D. Reding, N. Chatterjee, et al. Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial. Cancer Epidemiol Biomarkers Prev 2007; 16: 1303-5.

Tamizifar, B., K. Bagheri-Lankarani, S. Naeemi, M. Rismankar-Zadeh, A. Taghavi, and A. Ghaderi. Polymorphism of the promoter region of C-509T of transforming growth factor-beta1 gene and ulcerative colitis. Arch Iran Med 2007; 10: 171-5.

Liu, D.S., X.O. Li, B.W. Ying, L. Chen, T. Wang, D. Xu, et al. Effects of single nucleotide polymorphisms 869 T/C and 915 G/C in the exon 1 locus of transforming growth factor-beta1 gene on chronic obstructive pulmonary disease susceptibility in Chinese. Chin Med J (Engl) 2010; 123: 390-4.

Jakowlew, S.B. Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 2006; 25: 435-57.

Liu, Y., X.F. Lin, C.J. Lin, S.S. Jin, and J.M. Wu. Transforming growth factor beta-1 C-509T polymorphism and cancer risk: a meta-analysis of 55 case-control studies. Asian Pac J Cancer Prev 2012; 13: 4683-8.

Hu, S., G. Zhou, L. Zhang, H. Jiang, and M. Xiao. The effects of functional polymorphisms in the TGFbeta1 gene on nasopharyngeal carcinoma susceptibility. Otolaryngol Head Neck Surg 2012; 146: 579-84.

Guan, X., H. Zhao, J. Niu, D. Tan, J.A. Ajani, and Q. Wei. Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res 2009; 28: 94.

Zhang, J.M., X.J. Cui, Y.Q. Xia, and S. Guo. Correlation between TGF-beta1-509 C>T polymorphism and risk of digestive tract cancer in a meta-analysis for 21,196 participants. Gene 2012; 505: 66-74.

Tang, R.G., Y.Z. Huang, L.M. Yao, J. Xiao, C. Lu, and Q. Yu. Polymorphisms of transforming growth factor beta 1 (RS#1800468 and RS#1800471) and esophageal squamous cell carcinoma among Zhuangese population, China. Gene 2013; 512: 1-5.

Yuan, X., Q. Wei, R. Komaki, Z. Liu, J. Yang, S.L. Tucker, et al. Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy. PLoS One 2013; 8: e65659.

Zhang, L., G. Wu, F. Herrle, M. Niedergethmann, and M. Keese. Single nucleotide polymorphisms of genes for EGF, TGF-beta and TNF-alpha in patients with pancreatic carcinoma. Cancer Genomics Proteomics 2012; 9: 287-95.

Kubiczkova, L., L. Sedlarikova, R. Hajek, and S. Sevcikova. TGF-beta - an excellent servant but a bad master. J Transl Med 2012; 10: 183.